Letter from the Editor
Immunopharmacol Immunotoxicol
.
2017 Feb;39(1):1.
doi: 10.1080/08923973.2017.1264166.
Author
Anders Elm Pedersen
PMID:
28071184
DOI:
10.1080/08923973.2017.1264166
No abstract available
Publication types
Editorial
MeSH terms
Antibodies / adverse effects
Antibodies / therapeutic use*
Clinical Trials as Topic
Humans
Immunotherapy / adverse effects
Immunotherapy / methods*
Periodicals as Topic
Substances
Antibodies